XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity.  
Schedule of loss per common share

 

For the Three Months Ended September 30, 

 

For the Nine Months Ended September 30, 

 

    

2025

    

2024

    

2025

    

2024

Net Loss

$

(3,844)

$

(3,641)

$

(13,121)

$

(12,005)

Basic Weighted-Average Shares

 

34,043

 

31,619

 

33,906

 

29,055

Dilutive effect of potential common shares issuable (1)

 

 

 

 

Diluted Weighted-Average Shares

34,043

31,619

33,906

29,055

Loss per Common Share

 

  

 

  

 

  

 

  

Basic

$

(0.11)

$

(0.12)

$

(0.39)

$

(0.41)

Diluted

$

(0.11)

$

(0.12)

$

(0.39)

$

(0.41)

(1)For the three and nine months ended September 30, 2025, the Company had approximately 0.5 million and 0.6 million, respectively, of stock options, warrants, outstanding restricted stock units, and convertible debt excluded from the diluted shares calculation as their inclusion would be antidilutive due to a net loss for the respective periods. For both the three and nine months ended September 30, 2024, the Company had approximately 1.0 million of stock options, warrants, outstanding restricted stock units, and convertible debt as their effect would have been anti-dilutive due to a net loss for the respective periods.